Coronavirus Pandemic: Early results show pill by China’s Kintor Pharma can lower hospitalization risk by 92 percent and death by 78 percent

A Chinese drug-maker is reporting positive test results for its COVID pill. Early data from trials in Brazil appear promising, while more information is expected in the coming month. CGTN reporter Chen Tong reports from the company’s headquarters in Jiangsu Province.

Suzhou-based Kintor Pharma started to develop the drug shortly after the initial outbreak last year. Proxalutamide is the only small-molecule oral drug which has entered the phase III multi-regional clinical trial for treating COVID-19 inpatients.


Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s